Raskob GE, Van Es N, Verhamme P, et al. A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study. ASH 59th Annual Meeting & Exhibition, abstract LBA-6.
Beti-cel bij transfusie-afhankelijke ernstige bètathalassemie met β0 en β+IVS-I-110 genotypes
feb 2025 | Benigne hematologie